Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance

Abstract T2-weighted cardiovascular magnetic resonance (T2-CMR) of myocardial edema can quantify the area-at-risk (AAR) following acute myocardial infarction (AMI), and has been used to assess myocardial salvage by new cardioprotective therapies. However, some of these therapies may reduce edema, le...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rachel K. Dongworth, Adrienne E. Campbell-Washburn, Hector A. Cabrera-Fuentes, Heerajnarain Bulluck, Thomas Roberts, Anthony N. Price, Sauri Hernández-Reséndiz, Roger J. Ordidge, David L. Thomas, Derek M. Yellon, Mark F. Lythgoe, Derek J. Hausenloy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4b5a825347db4811b2bd0474faeac514
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b5a825347db4811b2bd0474faeac514
record_format dspace
spelling oai:doaj.org-article:4b5a825347db4811b2bd0474faeac5142021-12-02T12:30:11ZQuantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance10.1038/s41598-017-02544-z2045-2322https://doaj.org/article/4b5a825347db4811b2bd0474faeac5142017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02544-zhttps://doaj.org/toc/2045-2322Abstract T2-weighted cardiovascular magnetic resonance (T2-CMR) of myocardial edema can quantify the area-at-risk (AAR) following acute myocardial infarction (AMI), and has been used to assess myocardial salvage by new cardioprotective therapies. However, some of these therapies may reduce edema, leading to an underestimation of the AAR by T2-CMR. Here, we investigated arterial spin labeling (ASL) perfusion CMR as a novel approach to quantify the AAR following AMI. Adult B6sv129-mice were subjected to in vivo left coronary artery ligation for 30 minutes followed by 72 hours reperfusion. T2-mapping was used to quantify the edema-based AAR (% of left ventricle) following ischemic preconditioning (IPC) or cyclosporin-A (CsA) treatment. In control animals, the AAR by T2-mapping corresponded to that delineated by histology. As expected, both IPC and CsA reduced MI size. However, IPC, but not CsA, also reduced myocardial edema leading to an underestimation of the AAR by T2-mapping. In contrast, regions of reduced myocardial perfusion delineated by cardiac ASL were able to delineate the AAR when compared to both T2-mapping and histology in control animals, and were not affected by either IPC or CsA. Therefore, ASL perfusion CMR may be an alternative method for quantifying the AAR following AMI, which unlike T2-mapping, is not affected by IPC.Rachel K. DongworthAdrienne E. Campbell-WashburnHector A. Cabrera-FuentesHeerajnarain BulluckThomas RobertsAnthony N. PriceSauri Hernández-ReséndizRoger J. OrdidgeDavid L. ThomasDerek M. YellonMark F. LythgoeDerek J. HausenloyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rachel K. Dongworth
Adrienne E. Campbell-Washburn
Hector A. Cabrera-Fuentes
Heerajnarain Bulluck
Thomas Roberts
Anthony N. Price
Sauri Hernández-Reséndiz
Roger J. Ordidge
David L. Thomas
Derek M. Yellon
Mark F. Lythgoe
Derek J. Hausenloy
Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
description Abstract T2-weighted cardiovascular magnetic resonance (T2-CMR) of myocardial edema can quantify the area-at-risk (AAR) following acute myocardial infarction (AMI), and has been used to assess myocardial salvage by new cardioprotective therapies. However, some of these therapies may reduce edema, leading to an underestimation of the AAR by T2-CMR. Here, we investigated arterial spin labeling (ASL) perfusion CMR as a novel approach to quantify the AAR following AMI. Adult B6sv129-mice were subjected to in vivo left coronary artery ligation for 30 minutes followed by 72 hours reperfusion. T2-mapping was used to quantify the edema-based AAR (% of left ventricle) following ischemic preconditioning (IPC) or cyclosporin-A (CsA) treatment. In control animals, the AAR by T2-mapping corresponded to that delineated by histology. As expected, both IPC and CsA reduced MI size. However, IPC, but not CsA, also reduced myocardial edema leading to an underestimation of the AAR by T2-mapping. In contrast, regions of reduced myocardial perfusion delineated by cardiac ASL were able to delineate the AAR when compared to both T2-mapping and histology in control animals, and were not affected by either IPC or CsA. Therefore, ASL perfusion CMR may be an alternative method for quantifying the AAR following AMI, which unlike T2-mapping, is not affected by IPC.
format article
author Rachel K. Dongworth
Adrienne E. Campbell-Washburn
Hector A. Cabrera-Fuentes
Heerajnarain Bulluck
Thomas Roberts
Anthony N. Price
Sauri Hernández-Reséndiz
Roger J. Ordidge
David L. Thomas
Derek M. Yellon
Mark F. Lythgoe
Derek J. Hausenloy
author_facet Rachel K. Dongworth
Adrienne E. Campbell-Washburn
Hector A. Cabrera-Fuentes
Heerajnarain Bulluck
Thomas Roberts
Anthony N. Price
Sauri Hernández-Reséndiz
Roger J. Ordidge
David L. Thomas
Derek M. Yellon
Mark F. Lythgoe
Derek J. Hausenloy
author_sort Rachel K. Dongworth
title Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
title_short Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
title_full Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
title_fullStr Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
title_full_unstemmed Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
title_sort quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/4b5a825347db4811b2bd0474faeac514
work_keys_str_mv AT rachelkdongworth quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT adrienneecampbellwashburn quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT hectoracabrerafuentes quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT heerajnarainbulluck quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT thomasroberts quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT anthonynprice quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT saurihernandezresendiz quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT rogerjordidge quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT davidlthomas quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT derekmyellon quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT markflythgoe quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
AT derekjhausenloy quantifyingtheareaatriskofmyocardialinfarctioninvivousingarterialspinlabelingcardiacmagneticresonance
_version_ 1718394394811301888